The HER-2/neu story: from oncogene through prognostic marker to therapeutic strategy determinant and monoclonal therapy

Eur J Surg Oncol. 1999 Apr;25(2):111-2. doi: 10.1053/ejso.1998.0611.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Biomarkers, Tumor / metabolism*
  • Clinical Trials as Topic
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Neoplasms / immunology
  • Neoplasms / metabolism*
  • Neoplasms / therapy*
  • Prognosis
  • Receptor, ErbB-2 / immunology
  • Receptor, ErbB-2 / metabolism*
  • Up-Regulation

Substances

  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Receptor, ErbB-2